is retatrutide legal in canada Triple Agonist (GLP-1/GIP/GCG) ⚠️ BEWARE OF RETATRUTIDE SOLD

GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE- /- Mice

Retatrutide: Maintained at established dose (typically 8 to 12 mg weekly) BPC-157: 0.25 mg daily TB-500: 2.5 mg twice weekly (loading) or 2 mg weekly (maintenance) GHK-Cu: 0.1 to 0.2 mg three times weekly Duration: 8 to 12 weeks maximum, with 30-day minimum break between cycles The injection schedule for the complete GLOW protocol requires careful organization

Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, et al

rapid weight loss may also transiently alter joint mechanics during treatment